In vitroantifungal activity of antipsychotic drugs and their combinations with conventional antifungals againstScedosporiumandPseudallescheriaisolates

作者: Mónika Homa , László Galgóczy , Eszter Tóth , Liliána Tóth , Tamás Papp

DOI: 10.1093/MMY/MYV064

关键词:

摘要: In the present study, in vitro antifungal activities of five antipsychotic drugs (i.e., chlorpromazine hydrochloride, CPZ; trifluoperazine TPZ; amantadine hydrochloride; R-(-)-deprenyl and valproic acid sodium salt) conventional amphotericin B, AMB; caspofungin, CSP; itraconazole; terbinafine, TRB voriconazole, VRC) were investigated broth microdilution tests against four clinical environmental Scedosporium Pseudallescheria isolates. When used alone, phenothiazines CPZ TPZ exerted remarkable effects. Thus, their combinations with AMB, CSP, VRC, also examined combination agents, was able to act synergistically AMB cases one two isolates, respectively. all other cases, indifferent interactions revealed. Antagonism not observed between tested agents. These may establish a more effective less toxic therapy after further vivo studies for infections.

参考文章(45)
Tiffany J. Braley, Ronald D. Chervin, Fatigue in Multiple Sclerosis: Mechanisms, Evaluation, and Treatment Sleep. ,vol. 33, pp. 1061- 1067 ,(2010) , 10.1093/SLEEP/33.8.1061
Iftekhar Mahmood, Clinical pharmacokinetics and pharmacodynamics of selegiline. An update. Clinical Pharmacokinectics. ,vol. 33, pp. 91- 102 ,(1997) , 10.2165/00003088-199733020-00002
Niall J Crosby, Katherine Deane, Carl E Clarke, Amantadine in Parkinson's disease Cochrane Database of Systematic Reviews. ,(2003) , 10.1002/14651858.CD003468
Christopher H Heath, Monica A Slavin, Tania C Sorrell, Rosemary Handke, A Harun, Michael Phillips, Quoc Nguyen, Laurence Delhaes, David Ellis, Wieland Meyer, Sharon CA Chen, Australian Scedosporium Study Group, None, Population-based surveillance for scedosporiosis in Australia: epidemiology, disease manifestations and emergence of Scedosporium aurantiacum infection Clinical Microbiology and Infection. ,vol. 15, pp. 689- 693 ,(2009) , 10.1111/J.1469-0691.2009.02802.X
László Galgóczy, Andrea Bácsi, Mónika Homa, Máté Virágh, Tamás Papp, Csaba Vágvölgyi, In vitro antifungal activity of phenothiazines and their combination with amphotericin B against different Candida species. Mycoses. ,vol. 54, pp. 737- 743 ,(2011) , 10.1111/J.1439-0507.2010.02010.X
Sara E Dugan, Schizophrenia in Focus Annals of Pharmacotherapy. ,vol. 41, pp. 163- 163 ,(2007) , 10.1345/APH.1H499
Frank Telang, Colleen Shea, Youwen Xu, Lisa Muench, Joanna S Fowler, Jean Logan, Nora D Volkow, Elena Shumay, Fred McCall-Perez, Millard Jayne, Gene-Jack Wang, David L Alexoff, Karen Apelskog-Torres, Barbara Hubbard, Pauline Carter, Payton King, Stanley Fahn, Michelle Gilmor, Evidence that formulations of the selective MAO-B inhibitor, selegiline, which bypass first-pass metabolism, also inhibit MAO-A in the human brain. Neuropsychopharmacology. ,vol. 40, pp. 650- 657 ,(2015) , 10.1038/NPP.2014.214
Katharine E Black, Lindsey R Baden, Fungal infections of the CNS: treatment strategies for the immunocompromised patient. CNS Drugs. ,vol. 21, pp. 293- 318 ,(2007) , 10.2165/00023210-200721040-00004
Richard P. Bazinet, Margaret T. Weis, Stanley I. Rapoport, Thad A. Rosenberger, Valproic acid selectively inhibits conversion of arachidonic acid to arachidonoyl-CoA by brain microsomal long-chain fatty acyl-CoA synthetases: relevance to bipolar disorder Psychopharmacology. ,vol. 184, pp. 122- 129 ,(2006) , 10.1007/S00213-005-0272-4